83_FR_23683 83 FR 23584 - Medicare Program; CY 2018 Updates to the Quality Payment Program; and Quality Payment Program: Extreme and Uncontrollable Circumstance Policy for the Transition Year; Corrections

83 FR 23584 - Medicare Program; CY 2018 Updates to the Quality Payment Program; and Quality Payment Program: Extreme and Uncontrollable Circumstance Policy for the Transition Year; Corrections

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services

Federal Register Volume 83, Issue 99 (May 22, 2018)

Page Range23584-23610
FR Document2018-10923

This document corrects technical errors that appeared in the final rule with comment period and interim final rule with comment period published in the Federal Register on November 16, 2017 entitled ``Medicare Program; CY 2018 Updates to the Quality Payment Program; and Quality Payment Program: Extreme and Uncontrollable Circumstance Policy for the Transition Year'' (hereinafter referred to as the ``CY 2018 Quality Payment Program final rule'').

Federal Register, Volume 83 Issue 99 (Tuesday, May 22, 2018) 
[Federal Register Volume 83, Number 99 (Tuesday, May 22, 2018)]
[Rules and Regulations]
[Pages 23584-23610]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-10923]



[[Page 23584]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

42 CFR Part 414

[CMS-5522-F2]
RIN 0938-AT13


Medicare Program; CY 2018 Updates to the Quality Payment Program; 
and Quality Payment Program: Extreme and Uncontrollable Circumstance 
Policy for the Transition Year; Corrections

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Final rule with comment period and interim final rule with 
comment period; correction and correcting amendment.

-----------------------------------------------------------------------

SUMMARY: This document corrects technical errors that appeared in the 
final rule with comment period and interim final rule with comment 
period published in the Federal Register on November 16, 2017 entitled 
``Medicare Program; CY 2018 Updates to the Quality Payment Program; and 
Quality Payment Program: Extreme and Uncontrollable Circumstance Policy 
for the Transition Year'' (hereinafter referred to as the ``CY 2018 
Quality Payment Program final rule'').

DATES: This correction is effective May 22, 2018.

FOR FURTHER INFORMATION CONTACT: 
    Molly MacHarris, (410) 786-4461, for inquiries related to MIPS.
    Benjamin Chin, (410) 786-0679, for inquiries related to APMs.

SUPPLEMENTARY INFORMATION:

I. Background

    In FR Doc. 2017-24067 (82 FR 53568), the final rule with comment 
period and interim final rule with comment period there were a number 
of technical errors that are identified and corrected in the Correction 
of Errors section of this correcting document. The provisions in this 
correction document are effective as if they had been included in the 
document published in the Federal Register on November 16, 2017. 
Accordingly, the corrections are applicable for program years beginning 
January 1, 2018.

II. Summary of Errors

A. Summary of Errors in Preamble

    On page 53577, we inadvertently made an error in citing the 
incremental collection of information-related burden.
    On page 53743, we inadvertently made an error in identifying the 
regulation text citation.
    On page 53744, we inadvertently made an error in identifying the 
regulation text citation.
    On page 53900, we inadvertently made an error in citing the 
reduction in burden cost relative to a baseline of continuing the 
policies in the CY 2017 Quality Payment Program final rule.
    On page 53911, we inadvertently made an error in citing the 
estimated data submission burden for the Quality Payment Program.
    On page 53925, we inadvertently made an error in citing the total 
estimated labor cost for annual recordkeeping and data submission.
    On page 53925, we inadvertently made an error in citing the 
decrease in labor cost burden relative to the estimated baseline of 
continued transition year policies.
    On page 53925, Table 74--Annual Recordkeeping And Submission 
Requirements
    a. Sixth column titled ``Total annual burden cost'', second row, we 
inadvertently made an error in citing the total annual burden cost for 
QCDR and Registries self-nomination.
    b. Sixth column titled ``Total annual burden cost'', nineteenth 
row, we inadvertently made an error in citing the total annual burden 
cost.
    On page 53927, we inadvertently made an error in citing the 
reduction in burden costs in the Quality Payment Program Year 2 
relative to Quality Payment Program Year 1.
    On page 53950, we inadvertently made an error in citing the 
collection of information-related burden associated with the CY 2018 
Quality Payment Program final rule with comment period.
    On page 53950, we inadvertently made an error in citing the 
reduction in incremental collection of information-related burden 
associated with the CY 2018 Quality Payment Program final rule with 
comment period relative to the baseline burden of continuing the 
policies and information collections set forth in the CY 2017 Quality 
Program final rule.
    On page 53950, Table 81--Additional Costs And Benefits, in the 
second column titled ``Costs/benefits'', second row, we inadvertently 
made an error in citing the incremental collection of information/
Paperwork Reduction Act burden estimates.

B. Summary of Errors in Regulation Text

    On page 53954, in the regulation text at Sec.  
414.1370(g)(1)(ii)(B), we inadvertently made errors in identifying the 
beginning CY performance period for which CMS calculates a quality 
improvement score for an APM Entity.
    On page 53954, at 414.1370(h)(5)(i)(B), due to typographical 
errors, the percent values for the advancing care information 
performance category and the improvement activities performance 
category are incorrect.
    On page 53957, we inadvertently made an error in identifying the 
regulation text citation.
    On page 53961, at Sec.  414.1420(d)(3)(i), we inadvertently deleted 
the existing regulation text regarding the expected expenditures 
standard.

C. Summary of Errors in Appendix

    On page 53969, Table A.3. Average Change in Leg Pain following 
Lumbar Discectomy/Laminotomy, Quality #461, we inadvertently omitted 
the MAP recommendation description in the ``Rationale''.
    On page 53970, Table A.4. Bone Density Evaluation for Patients with 
Prostate Cancer and Receiving Androgen Deprivation Therapy, Quality 
#462, we incorrectly identified the MAP recommendation description in 
the ``Rationale''.
    On page 53971, Table A.5. Prevention of Post-Operative Vomiting 
(POV)--Combination Therapy (Pediatrics), Quality #463 we inadvertently 
omitted the MAP recommendation description in the ``Rationale''.
    On page 53973, Table A.7. Uterine Artery Embolization Technique: 
Documentation of Angiographic Endpoints and Interrogation of Ovarian 
Arteries, Quality #465, we inadvertently omitted the MAP recommendation 
description in the ``Rationale''.
    On page 53976, Table B.1. Allergy/Immunology in the first column 
titled ``Indicator'', third row, we inadvertently omitted the high 
priority symbol.
    On page 53977, Table B.1. Allergy/Immunology (continued) in the 
first column titled ``Indicator'', second row, we inadvertently omitted 
the high priority symbol.
    On page 53978, Table B.1. Allergy/Immunology (continued) in the 
first column titled ``Indicator'', third row, we inadvertently omitted 
the CORE measure and the high priority symbols.
    On page 53985, Table B.3. Cardiology (continued) in the first 
column titled ``Indicator'',
    a. Third row, we inadvertently omitted the CORE measure and the 
high priority symbols.
    b. Fourth row, we inadvertently omitted the high priority symbol.
    On page 53986, Table B.3. Cardiology (continued) in the first 
column titled

[[Page 23585]]

``Indicator'', first row, we inadvertently omitted the high priority 
symbol.
    On page 53987, Table B.3. Cardiology (continued) in the first 
column titled ``Indicator'', fifth row, we inadvertently omitted the 
high priority symbol.
    On page 53992, Table B.4. Gastroenterology (continued) in the first 
column titled ``Indicator'', third row, we inadvertently omitted the 
CORE measure symbol.
    On page 53997, Table B.5. Dermatology (continued),
    a. First column titled ``Indicator'', third row, we inadvertently 
omitted the high priority symbol.
    b. Fifth column titled ``Data Submission Method'', second row, we 
inadvertently listed an incorrect claims submission method.
    On page 54006, Table B.7. Family Medicine (continued) in the fourth 
column titled ``CMS E-measure ID'', fifth row, we inadvertently listed 
an incorrect E-measure ID.
    On page 54007, Table B.7. Family Medicine (continued) in the first 
column titled ``Indicator'', second row, we inadvertently omitted the 
high priority symbol.
    On page 54009, Table B.7. Family Medicine (continued) in the first 
column titled ``Indicator'', first and second rows, we inadvertently 
omitted the high priority symbol.
    On page 54010, Table B.7. Family Medicine (continued),
    a. Second column titled ``NQF#'', third row, due to a typographical 
error, we included an incorrect NQF#.
    b. Ninth column titled ``Measure Steward'', third row, we 
inadvertently omitted the Centers for Medicare & Medicaid Services 
(CMS) as a co-steward.
    On page 54012, Table B.7. Family Medicine (continued) in the first 
column titled ``Indicator'', fifth row, we inadvertently omitted the 
high priority symbol.
    On page 54013, Table B.7. Family Medicine (continued) in the first 
column titled ``Indicator'', first row, we inadvertently omitted the 
high priority symbol.
    On page 54023, Table B.8. Internal Medicine (continued), in the 
first column titled ``Indicator'', First and second rows, we 
inadvertently omitted the high priority symbol.
    On pages 54024, Table B.8. Internal Medicine (continued),
    a. Second column titled ``NQF#'', third row, due to a typographical 
error, we included an incorrect NQF#.
    b. Ninth column titled ``Measure Steward'', third row, we 
inadvertently omitted the Centers for Medicare & Medicaid Services 
(CMS) as a co-steward.
    On page 54027, Table B.8. Internal Medicine (continued), in the 
first column titled ``Indicator'', third and fifth rows, we 
inadvertently omitted the high priority symbol.
    On page 54036, Table B.9. Obstetrics/Gynecology (continued), in the 
first column titled ``Indicator'', sixth row, we inadvertently omitted 
the high priority symbol.
    On page 54037, Table B.9. Obstetrics/Gynecology (continued), in the 
first column titled ``Indicator'', second and fourth rows, we 
inadvertently omitted the high priority symbol.
    On page 54038, Table B.9. Obstetrics/Gynecology (continued), ninth 
column, fourth row, we inadvertently listed an incorrect measure 
steward.
    On page 54047, Table B.11. Orthopedic Surgery (continued) in the 
first column titled ``Indicator'', fifth row, we inadvertently omitted 
the high priority symbol.
    On page 54049, Table B.11. Orthopedic Surgery (continued) in the 
first column titled ``Indicator'', third row, we inadvertently omitted 
the substantive change symbol.
    On page 54079, Table B.18. Neurology (continued) in the first 
column titled ``Indicator'',
    a. Third and fourth rows, we inadvertently omitted the substantive 
change symbol.
    b. Third row, the measure title and description are inconsistent 
with the finalized substantive change, which is described in Table 
E.12.
    On page 54082, for Table B.18. Neurology (continued), we 
inadvertently included duplicate entries for Quality #286.
    On page 54086, Table B.19. Mental/Behavioral Health (continued) in 
the first column titled ``Indicator'',
    a. Third row, we inadvertently omitted the substantive change 
symbol.
    b. Third row, the measure title and description are inconsistent 
with the finalized substantive change, which is described in Table 
E.12.
    On page 54089, Table B.19. Mental/Behavioral Health (continued) in 
the fourth column titled ``CMS E-Measure ID'', fourth row, we 
inadvertently listed an incorrect E-measure ID.
    On page 54091, Table B.19. Mental/Behavioral Health (continued), we 
inadvertently included duplicate entries for Quality #286.
    On page 54094, Table B.20a. Diagnostic Radiology (continued) in the 
first column titled ``Indicator'', first row, we inadvertently omitted 
the high priority symbol.
    On page 54098, Table B.20b. Interventional Radiology (continued) in 
the first column titled ``Indicator'', fifth row, we inadvertently 
omitted the high priority symbol.
    On page 54099, Table B.20b. Interventional Radiology (continued) in 
the first column titled ``Indicator'', second row, we inadvertently 
omitted the high priority symbol.
    On page 54102, Table B.21. Nephrology (continued) in the first 
column titled ``Indicator'', second row, we inadvertently omitted the 
high priority symbol.
    On page 54103, Table B.21. Nephrology (continued) in the first 
column titled ``Indicator'',
    a. First and third rows, we inadvertently omitted the high priority 
symbol.
    b. Second row, we inadvertently omitted the CORE measure symbol.
    On page 54109, Table B.23. Vascular Surgery (continued) in the 
first column titled ``Indicator'', third row, we inadvertently omitted 
the high priority and CORE measure symbols.
    On page 54112, Table B.23. Vascular Surgery (continued) in the 
first column titled ``Indicator'', third row, we inadvertently omitted 
the high priority symbol.
    On page 54113, Table B.23. Vascular Surgery (continued) in the 
third column titled ``Quality#'', first row, due to a typographical 
error, the Quality# for the measure title and description was 
incorrect.
    On page 54116, Table B.24. Thoracic Surgery (continued) in the 
first column titled ``Indicator'', fourth row, we inadvertently omitted 
the high priority and CORE measure symbols.
    On page 54118, Table B.24. Thoracic Surgery (continued) in the 
first column titled ``Indicator'', first row, we inadvertently omitted 
the high priority and CORE measure symbols.
    On page 54121, Table B.25. Urology (continued) in the first column 
titled ``Indicator'', first row, we inadvertently omitted the high 
priority symbol.
    On page 54122, Table B.25. Urology (continued) in the first column 
titled ``Indicator'', fifth row, we inadvertently omitted the high 
priority symbol.
    On page 54123, Table B.25. Urology (continued) in the first column 
titled ``Indicator'',
    a. First, second, and third rows, we inadvertently omitted the high 
priority symbol.
    On page 54124, Table B.26. Oncology in the first column titled 
``Indicator'', third row, we inadvertently omitted the high priority 
symbol.
    On page 54130, Table B.27. Hospitalists (continued) in the first 
column titled ``Indicator'', first row, we inadvertently omitted the 
high priority symbol.

[[Page 23586]]

    On page 54134, Table B.28. Rheumatology (continued) in the first 
column titled ``Indicator'', second row, we inadvertently omitted the 
high priority symbol.
    On page 54136, Table B.29. Infectious Disease (continued) in the 
first column titled ``Indicator'', second row, we inadvertently omitted 
the high priority symbol.
    On page 54137, Table B.29. Infectious Disease (continued) in the 
first column titled ``Indicator'', second row, we inadvertently omitted 
the CORE measure symbol.
    On page 54138, Table B.29. Infectious Disease (continued) in the 
first column titled ``Indicator'', fifth row, we inadvertently omitted 
the high priority and CORE measure symbols.
    On page 54139, Table B.29. Infectious Disease (continued) in the 
first column titled ``Indicator'', first row, we inadvertently omitted 
the high priority symbol.
    On page 54141, Table B.30. Neurosurgical (continued) in the first 
column titled ``Indicator'', third row, we inadvertently omitted the 
high priority symbol.
    On page 54142, Table B.30. Neurosurgical (continued) in the first 
column titled ``Indicator'',
    a. Fourth and fifth rows, we inadvertently omitted the high 
priority symbol.
    On page 54145, Table B.31. Podiatry (continued) in the first column 
titled ``Indicator'', first row, we inadvertently omitted the CORE 
measure symbol.
    On page 54146, Table B.32. Dentistry (continued) in the first 
column titled ``Indicator'', first row, we inadvertently omitted the 
high priority symbol.
    On page 54163, Table E.1. CAHPS for MIPS Clinician/Group Survey
    a. First row titled ``NQF#'', due to a typographical error, we 
included an incorrect NQF#.
    b. Seventh row titled ``Substantive Change'', we inadvertently 
omitted the SSMs that remain for the measure.
    c. Eighth row titled ``Steward'', we inadvertently omitted the 
Centers for Medicare & Medicaid Services (CMS) as a co-steward.
    On page 54204, in Table G: Improvement Activities with Changes for 
the Quality Payment Program Year 2 and Future Years,
    a. Eighteenth row, titled ``Response'', we inadvertently added 
qualifier language that was incorrect.
    b. Nineteenth row, titled ``Rationale'' we inadvertently added 
qualifier language that was incorrect.
    On page 54216, in Table G: Improvement Activities with Changes for 
the Quality Payment Program Year 2 and Future Years, thirty-ninth row, 
titled ``Currently Eligible for Advancing Care Information Bonus'', we 
incorrectly stated that this activity was not eligible for the 
Advancing Care Information Bonus. IA_PM_13 is eligible for the 
Advancing Care Information Bonus.

III. Waiver of Proposed Rulemaking, 60-Day Comment Period, and Delay in 
Effective Date

    Under 5 U.S.C. 553(b) of the Administrative Procedure Act (APA), 
the agency is required to publish a notice of the proposed rule in the 
Federal Register before the provisions of a rule take effect. 
Similarly, section 1871(b)(1) of the Act requires the Secretary to 
provide for notice of the proposed rule in the Federal Register and 
provide a period of not less than 60 days for public comment. In 
addition, section 553(d) of the APA, and section 1871(e)(1)(B)(i) of 
the Act mandate a 30-day delay in effective date after issuance or 
publication of a rule. Sections 553(b)(B) and 553(d)(3) of the APA 
provide for exceptions from the notice and comment and delay in 
effective date APA requirements; in cases in which these exceptions 
apply, sections 1871(b)(2)(C) and 1871(e)(1)(B)(ii) of the Act provide 
exceptions from the notice and 60-day comment period and delay in 
effective date requirements of the Act as well. Section 553(b)(B) of 
the APA and section 1871(b)(2)(C) of the Act authorize an agency to 
dispense with normal rulemaking requirements for good cause if the 
agency makes a finding that the notice and comment process are 
impracticable, unnecessary, or contrary to the public interest. In 
addition, both section 553(d)(3) of the APA and section 
1871(e)(1)(B)(ii) of the Act allow the agency to avoid the 30-day delay 
in effective date where such delay is contrary to the public interest 
and an agency includes a statement of support.
    We believe that this correcting document does not constitute a rule 
that would be subject to the notice and comment or delayed effective 
date requirements. The document corrects technical errors in the CY 
2018 Quality Payment Program final rule, but does not make substantive 
changes to the policies or payment methodologies that were adopted in 
the final rule. As a result, this correcting document is intended to 
ensure that the information in the CY 2018 Quality Payment Program 
final rule accurately reflects the policies adopted in that document.
    In addition, even if this were a rule to which the notice and 
comment procedures and delayed effective date requirements applied, we 
find that there is good cause to waive such requirements. Undertaking 
further notice and comment procedures to incorporate the corrections in 
this document into the final rule or delaying the effective date would 
be contrary to the public interest because it is in the public's 
interest for providers to receive appropriate payments in as timely a 
manner as possible, and to ensure that the CY 2018 Quality Payment 
Program final rule accurately reflects our methodologies and policies. 
Furthermore, such procedures would be unnecessary, as we are not making 
substantive changes to our methodologies or policies, but rather, we 
are simply implementing correctly the methodologies and policies that 
we previously proposed, requested comment on, and subsequently 
finalized. This correcting document is intended solely to ensure that 
the CY 2018 Quality Payment Program final rule accurately reflects 
these methodologies and policies. Therefore, we believe we have good 
cause to waive the notice and comment and effective date requirements.

IV. Correction of Errors

    In FR Doc. 2017-24067 (82 FR 53568), make the following 
corrections:

A. Correction of Errors in Preamble

    1. On page 53577, second column, second full paragraph, line 10, 
the phrase ``of approximately $13.9 million relative'' is corrected to 
read ``of approximately $14.2 million relative''.
    2. On page 53743, second column, first full paragraph, under the 
heading ``(iii) Additional Requirement for Full Participation To 
Measure Improvement for Quality Performance Category'', line 7, the 
reference ``Sec.  414.1330'' is corrected to read ``Sec.  414.1335''.
    3. On page 53744, third column, third full paragraph, line 6, the 
reference ``Sec.  414.1330'' is corrected to read ``Sec.  414.1335''.
    4. On page 53900, second column, first partial paragraph, line 7, 
the phrase ``burden cost of approximately $13.9'' is corrected to read 
``burden cost of approximately $14.2''.
    5. On page 53911, third column, second full paragraph, line 3, the 
phrase ``approximately $695 million'' is corrected to read 
``approximately $694 million''.
    6. On page 53925, first column, second full paragraph, line 6, the 
phrase ``total labor cost of $694,183,802'' is corrected to read 
``total labor cost of ``$693,949,289''.
    7. On page 53925, third column, first full paragraph, line 3, the 
phrase ``by 171,264 hours and $13.9 million in'' is

[[Page 23587]]

corrected to read ``by 171,264 hours and $14.2 million in''.
    8. On page 53925, in Table 74--Annual Recordkeeping And Submission 
Requirements, sixth column, row 2, the total annual burden cost for 
QCDR and Registries self-nomination ``439,786'' is corrected to read 
``205,273''.
    9. On page 53925, in Table 74--Annual Recordkeeping And Submission 
Requirements, sixth column, row 19, the total annual burden cost 
``694,183,802'' is corrected to read ``693,949,289''.
    10. On page 53927, first column, first partial paragraph, line 4, 
the phrase ``costs of $13.9 million in the Quality'' is corrected to 
read ``costs of $14.2 million in the Quality''.
    11. On page 53950, first column, first full paragraph, line 4, the 
phrase ``will result in approximately $695'' is corrected to read 
``will result in approximately $694''.
    12. On page 53950, second column, first partial paragraph, line 2, 
the phrase ``period is and approximately $13.9'' is corrected to read 
``period is and approximately $14.2''.
    13. On page 53950, Table 81, Additional Costs And Benefits second 
column, Costs/benefits second row, the dollar value ``$13.9 million'' 
is corrected to read ``$14.2 million''.

B. Correction of Errors in Appendix

    1. On page 53969, in Table A.3. Average Change in Leg Pain 
following Lumbar Discectomy/Laminotomy, the listed entry is corrected 
to read as follows:
BILLING CODE 4120-01-P
[GRAPHIC] [TIFF OMITTED] TR22MY18.000

    2. On page 53970, in Table A.4. Bone Density Evaluation for 
Patients with Prostate Cancer and Receiving Androgen Deprivation 
Therapy, the listed entry is corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.001

    3. On page 53971, in Table A.5, Prevention of Post-Operative 
Vomiting (POV)--Combination Therapy (Pediatrics) the listed entry is 
corrected to read as follows:

[[Page 23588]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.002

    4. On page 53973, in Table A.7, Uterine Artery Embolization 
Technique: Documentation of Angiographic Endpoints and Interrogation of 
Ovarian Arteries, the listed entry is corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.003

    5. On pages 53976, 53977 and 53978, in Table B.1 Allergy/
Immunology, the listed entries are corrected to read as follows:

[[Page 23589]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.004

    6. On pages 53985, 53986, and 53987, in Table B.3 Cardiology 
(continued), the listed entries are corrected to read as follows:

[[Page 23590]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.005

    7. On page 53992, in Table B.4 Gastroenterology (continued), the 
listed entry is corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.006

    8. On page 53997, in Table B.5 Dermatology (continued), the listed 
entries are corrected to read as follows:

[[Page 23591]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.007

    9. On page 54006, 54007, 54009, 54010, 54012, and 54013, in Table 
B.7 Family Medicine (continued) the listed entries are corrected to 
read as follows:

[[Page 23592]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.008


[[Page 23593]]


[GRAPHIC] [TIFF OMITTED] TR22MY18.009

    10. On pages 54023, 54024, and 54027, in Table B.8 Internal 
Medicine (continued), the listed entries are corrected to read as 
follows:

[[Page 23594]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.010


[[Page 23595]]


[GRAPHIC] [TIFF OMITTED] TR22MY18.011

    11. On pages 54036, 54037, and 54038, in Table B.9 Obstetrics/
Gynecology (continued), the listed entries are corrected to read as 
follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.012

    12. On pages 54047 and 54049, in Table B.11 Orthopedic Surgery 
(continued), the listed entries are corrected to read as follows:

[[Page 23596]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.013

    13. On page 54079, in Table B.18 Neurology (continued), the listed 
entries are corrected to read as follows:

[[Page 23597]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.014

    14. On page 54082, in Table B.18 Neurology (continued), the third 
row (including the Quality #286) is removed.
    15. On page 54086, 54089, and 54091, in Table B.19 Mental/
Behavioral Health (continued), the listed entries are corrected to read 
as follows:

[[Page 23598]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.015

    16. On page 54091, in Table B.19 Mental/Behavioral Health 
(continued), the third row (including the Quality #286) is removed.
    17. On page 54094, in Table B.20a Diagnostic Radiology (continued), 
the listed entry is corrected to read as follows:

[[Page 23599]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.016

    18. On page 54098 and 54099, in Table B.20b Interventional 
Radiology, the listed entries are corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.017

    19. On pages 54102 and 54103, in Table B.21 Nephrology (continued), 
the listed entries are corrected to read as follows:

[[Page 23600]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.018

    20. On pages 54109, 54112, and 54113, in Table B.23 Vascular 
Surgery (continued), the listed entries are corrected to read as 
follows:

[[Page 23601]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.019

    21. On pages 54116 and 54118, in Table B.24 Thoracic Surgery 
(continued), the listed entries are corrected to read as follows:

[[Page 23602]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.020

    22. On page 54121, 54122, and 54123, in Table B.25 Urology 
(continued), the listed entries are corrected to read as follows:

[[Page 23603]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.021

    23. On page 54124, in Table B.26 Oncology, the listed entry is 
corrected to read as follows:

[[Page 23604]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.022

    24. On page 54130, in Table B.27 Hospitalists (continued), the 
listed entry is corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.023

    25. On page 54134, Table B.28 Rheumatology (continued), the listed 
entry is corrected to read as follows:

[[Page 23605]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.024

    26. On pages 54136, 54137, 54138, and 54139, in Table B.29. 
Infectious Disease (continued), the listed entries are corrected to 
read as follows:

[[Page 23606]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.025

    27. On pages 54141 and 54142, in Table B.30 Neurosurgical, the 
listed entries are corrected to read as follows:

[[Page 23607]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.026

    28. On page 54145, in Table B.31 Podiatry (continued), the listed 
entry is corrected to read as follows:

[[Page 23608]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.027

    29. On page 54146, in Table B.32 Dentistry, the listed entry is 
corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.028

    30. On page 54163, in Table E.1, CAHPS for MIPS Clinician/Group 
Survey, the listed entries are corrected to read as follows:

[[Page 23609]]

[GRAPHIC] [TIFF OMITTED] TR22MY18.029

    31. On page 54204, in Table G Improvement Activities with Changes 
for the Quality Payment Program Year 2 and Future Years, the following 
entries are corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.030

    32. On page 54216, in Table G Improvement Activities with Changes 
for the Quality Payment Program Year 2 and Future Years, the following 
entries are corrected to read as follows:
[GRAPHIC] [TIFF OMITTED] TR22MY18.031

BILLING CODE 4120-01-C

List of Subjects in 42 CFR Part 414

    Administrative practice and procedure, Biologics, Drugs, Health 
facilities, Health professions, Diseases, Medicare, Reporting and 
recordkeeping requirements.

    Accordingly, 42 CFR chapter IV is corrected by making the following 
correcting amendments:

[[Page 23610]]

PART 414--PAYMENT FOR PART B MEDICAL AND OTHER HEALTH SERVICES

0
1. The authority citation for part 414 continues to read as follows:

    Authority: Secs. 1102, 1871, and 1881(b)(l) of the Social 
Security Act (42 U.S.C. 1302, 1395hh, and 1395rr(b)(l)).

0
2. Section 414.1370 is amended by revising paragraphs (g)(1)(ii)(B) and 
(h)(5)(i)(B) to read as follows:


Sec.  414.1370  APM scoring standard under MIPS.

* * * * *
    (g) * * *
    (1) * * *
    (ii) * * *
    (B) Quality Improvement Score. Beginning in 2018, for an APM Entity 
for which CMS calculated a total quality performance category score for 
the previous MIPS performance period, CMS calculates a quality 
improvement score for the APM Entity group, as specified in Sec.  
414.1380(b)(1)(xvi).
* * * * *
    (h) * * *
    (5) * * *
    (i) * * *
    (B) Beginning in 2018, the advancing care information performance 
category is reweighted to 75 percent and the improvement activities 
performance category is reweighted to 25 percent.
* * * * *


Sec.  414.1380  [Amended]

0
3. Section 414.1380 is amended in paragraph (b)(1)(xvi)(F) by removing 
the reference ``Sec. Sec.  414.1330'' and adding in its place the 
reference ``Sec. Sec.  414.1335''.

0
4. Section 414.1420 is amended by revising paragraph (d)(3)(i) to read 
as follows:


Sec.  414.1420  Other payer advanced APM criteria.

* * * * *
    (d) * * *
    (3) * * *
    (i) For the 2019 and 2020 QP Performance Periods, 8 percent of the 
total combined revenues from the payer to providers and other entities 
under the payment arrangement if financial risk is expressly defined in 
terms of revenue; or, 3 percent of the expected expenditures for which 
an APM Entity is responsible under the payment arrangement; or
* * * * *

    Dated: May 16. 2018.
Ann C. Agnew,
Executive Secretary to the Department, Department of Health and Human 
Services.
[FR Doc. 2018-10923 Filed 5-21-18; 8:45 am]
 BILLING CODE 4120-01-P

23584 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations DEPARTMENT OF HEALTH AND On page 53743, we inadvertently the beginning CY performance period HUMAN SERVICES made an error in identifying the for which CMS calculates a quality regulation text citation. improvement score for an APM Entity. Centers for Medicare & Medicaid On page 53744, we inadvertently On page 53954, at Services made an error in identifying the 414.1370(h)(5)(i)(B), due to regulation text citation. typographical errors, the percent values 42 CFR Part 414 On page 53900, we inadvertently for the advancing care information made an error in citing the reduction in performance category and the [CMS–5522–F2] burden cost relative to a baseline of improvement activities performance RIN 0938–AT13 continuing the policies in the CY 2017 category are incorrect. Quality Payment Program final rule. On page 53957, we inadvertently Medicare Program; CY 2018 Updates to On page 53911, we inadvertently made an error in identifying the the Quality Payment Program; and made an error in citing the estimated regulation text citation. Quality Payment Program: Extreme data submission burden for the Quality On page 53961, at § 414.1420(d)(3)(i), and Uncontrollable Circumstance Payment Program. we inadvertently deleted the existing Policy for the Transition Year; On page 53925, we inadvertently regulation text regarding the expected Corrections made an error in citing the total expenditures standard. AGENCY: Centers for Medicare & estimated labor cost for annual recordkeeping and data submission. C. Summary of Errors in Appendix Medicaid Services (CMS), HHS. On page 53925, we inadvertently On page 53969, Table A.3. Average ACTION: Final rule with comment period made an error in citing the decrease in Change in Leg Pain following Lumbar and interim final rule with comment labor cost burden relative to the Discectomy/Laminotomy, Quality #461, period; correction and correcting estimated baseline of continued we inadvertently omitted the MAP amendment. transition year policies. recommendation description in the SUMMARY: This document corrects On page 53925, Table 74—Annual ‘‘Rationale’’. technical errors that appeared in the Recordkeeping And Submission On page 53970, Table A.4. Bone final rule with comment period and Requirements Density Evaluation for Patients with interim final rule with comment period a. Sixth column titled ‘‘Total annual Prostate Cancer and Receiving published in the Federal Register on burden cost’’, second row, we Androgen Deprivation Therapy, Quality November 16, 2017 entitled ‘‘Medicare inadvertently made an error in citing the #462, we incorrectly identified the MAP Program; CY 2018 Updates to the total annual burden cost for QCDR and recommendation description in the Quality Payment Program; and Quality Registries self-nomination. ‘‘Rationale’’. Payment Program: Extreme and b. Sixth column titled ‘‘Total annual On page 53971, Table A.5. Prevention Uncontrollable Circumstance Policy for burden cost’’, nineteenth row, we of Post-Operative Vomiting (POV)— the Transition Year’’ (hereinafter inadvertently made an error in citing the Combination Therapy (Pediatrics), referred to as the ‘‘CY 2018 Quality total annual burden cost. Quality #463 we inadvertently omitted Payment Program final rule’’). On page 53927, we inadvertently the MAP recommendation description made an error in citing the reduction in in the ‘‘Rationale’’. DATES: This correction is effective May burden costs in the Quality Payment On page 53973, Table A.7. Uterine 22, 2018. Program Year 2 relative to Quality Artery Embolization Technique: FOR FURTHER INFORMATION CONTACT: Payment Program Year 1. Documentation of Angiographic Molly MacHarris, (410) 786–4461, for On page 53950, we inadvertently Endpoints and Interrogation of Ovarian inquiries related to MIPS. made an error in citing the collection of Benjamin Chin, (410) 786–0679, for Arteries, Quality #465, we inadvertently information-related burden associated omitted the MAP recommendation inquiries related to APMs. with the CY 2018 Quality Payment description in the ‘‘Rationale’’. SUPPLEMENTARY INFORMATION: Program final rule with comment On page 53976, Table B.1. Allergy/ I. Background period. Immunology in the first column titled On page 53950, we inadvertently ‘‘Indicator’’, third row, we inadvertently In FR Doc. 2017–24067 (82 FR 53568), made an error in citing the reduction in omitted the high priority symbol. the final rule with comment period and incremental collection of information- On page 53977, Table B.1. Allergy/ interim final rule with comment period related burden associated with the CY Immunology (continued) in the first there were a number of technical errors 2018 Quality Payment Program final column titled ‘‘Indicator’’, second row, that are identified and corrected in the rule with comment period relative to the we inadvertently omitted the high Correction of Errors section of this baseline burden of continuing the priority symbol. correcting document. The provisions in policies and information collections set On page 53978, Table B.1. Allergy/ this correction document are effective as forth in the CY 2017 Quality Program Immunology (continued) in the first if they had been included in the final rule. column titled ‘‘Indicator’’, third row, we document published in the Federal On page 53950, Table 81—Additional inadvertently omitted the CORE Register on November 16, 2017. Costs And Benefits, in the second measure and the high priority symbols. Accordingly, the corrections are column titled ‘‘Costs/benefits’’, second On page 53985, Table B.3. Cardiology applicable for program years beginning row, we inadvertently made an error in (continued) in the first column titled January 1, 2018. citing the incremental collection of ‘‘Indicator’’, II. Summary of Errors information/Paperwork Reduction Act a. Third row, we inadvertently amozie on DSK3GDR082PROD with RULES burden estimates. omitted the CORE measure and the high A. Summary of Errors in Preamble priority symbols. On page 53577, we inadvertently B. Summary of Errors in Regulation Text b. Fourth row, we inadvertently made an error in citing the incremental On page 53954, in the regulation text omitted the high priority symbol. collection of information-related at § 414.1370(g)(1)(ii)(B), we On page 53986, Table B.3. Cardiology burden. inadvertently made errors in identifying (continued) in the first column titled VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00010 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23585 ‘‘Indicator’’, first row, we inadvertently On page 54027, Table B.8. Internal row, we inadvertently omitted the high omitted the high priority symbol. Medicine (continued), in the first priority symbol. On page 53987, Table B.3. Cardiology column titled ‘‘Indicator’’, third and On page 54099, Table B.20b. (continued) in the first column titled fifth rows, we inadvertently omitted the Interventional Radiology (continued) in ‘‘Indicator’’, fifth row, we inadvertently high priority symbol. the first column titled ‘‘Indicator’’, omitted the high priority symbol. On page 54036, Table B.9. Obstetrics/ second row, we inadvertently omitted On page 53992, Table B.4. Gynecology (continued), in the first the high priority symbol. Gastroenterology (continued) in the first column titled ‘‘Indicator’’, sixth row, we On page 54102, Table B.21. column titled ‘‘Indicator’’, third row, we inadvertently omitted the high priority Nephrology (continued) in the first inadvertently omitted the CORE symbol. column titled ‘‘Indicator’’, second row, measure symbol. On page 54037, Table B.9. Obstetrics/ we inadvertently omitted the high On page 53997, Table B.5. Gynecology (continued), in the first priority symbol. Dermatology (continued), column titled ‘‘Indicator’’, second and On page 54103, Table B.21. a. First column titled ‘‘Indicator’’, fourth rows, we inadvertently omitted Nephrology (continued) in the first third row, we inadvertently omitted the the high priority symbol. column titled ‘‘Indicator’’, high priority symbol. On page 54038, Table B.9. Obstetrics/ a. First and third rows, we b. Fifth column titled ‘‘Data Gynecology (continued), ninth column, inadvertently omitted the high priority Submission Method’’, second row, we fourth row, we inadvertently listed an symbol. inadvertently listed an incorrect claims incorrect measure steward. b. Second row, we inadvertently submission method. On page 54047, Table B.11. omitted the CORE measure symbol. On page 54006, Table B.7. Family Orthopedic Surgery (continued) in the On page 54109, Table B.23. Vascular Medicine (continued) in the fourth first column titled ‘‘Indicator’’, fifth Surgery (continued) in the first column column titled ‘‘CMS E-measure ID’’, row, we inadvertently omitted the high titled ‘‘Indicator’’, third row, we fifth row, we inadvertently listed an priority symbol. inadvertently omitted the high priority incorrect E-measure ID. On page 54049, Table B.11. and CORE measure symbols. On page 54007, Table B.7. Family On page 54112, Table B.23. Vascular Orthopedic Surgery (continued) in the Medicine (continued) in the first Surgery (continued) in the first column first column titled ‘‘Indicator’’, third column titled ‘‘Indicator’’, second row, titled ‘‘Indicator’’, third row, we row, we inadvertently omitted the we inadvertently omitted the high inadvertently omitted the high priority substantive change symbol. priority symbol. symbol. On page 54009, Table B.7. Family On page 54079, Table B.18. Neurology (continued) in the first column titled On page 54113, Table B.23. Vascular Medicine (continued) in the first ‘‘Indicator’’, Surgery (continued) in the third column column titled ‘‘Indicator’’, first and a. Third and fourth rows, we titled ‘‘Quality#’’, first row, due to a second rows, we inadvertently omitted inadvertently omitted the substantive typographical error, the Quality# for the the high priority symbol. On page 54010, Table B.7. Family change symbol. measure title and description was Medicine (continued), b. Third row, the measure title and incorrect. a. Second column titled ‘‘NQF#’’, description are inconsistent with the On page 54116, Table B.24. Thoracic third row, due to a typographical error, finalized substantive change, which is Surgery (continued) in the first column we included an incorrect NQF#. described in Table E.12. titled ‘‘Indicator’’, fourth row, we b. Ninth column titled ‘‘Measure On page 54082, for Table B.18. inadvertently omitted the high priority Steward’’, third row, we inadvertently Neurology (continued), we and CORE measure symbols. omitted the Centers for Medicare & inadvertently included duplicate entries On page 54118, Table B.24. Thoracic Medicaid Services (CMS) as a co- for Quality #286. Surgery (continued) in the first column steward. On page 54086, Table B.19. Mental/ titled ‘‘Indicator’’, first row, we On page 54012, Table B.7. Family Behavioral Health (continued) in the inadvertently omitted the high priority Medicine (continued) in the first first column titled ‘‘Indicator’’, and CORE measure symbols. column titled ‘‘Indicator’’, fifth row, we a. Third row, we inadvertently On page 54121, Table B.25. Urology inadvertently omitted the high priority omitted the substantive change symbol. (continued) in the first column titled symbol. b. Third row, the measure title and ‘‘Indicator’’, first row, we inadvertently On page 54013, Table B.7. Family description are inconsistent with the omitted the high priority symbol. Medicine (continued) in the first finalized substantive change, which is On page 54122, Table B.25. Urology column titled ‘‘Indicator’’, first row, we described in Table E.12. (continued) in the first column titled inadvertently omitted the high priority On page 54089, Table B.19. Mental/ ‘‘Indicator’’, fifth row, we inadvertently symbol. Behavioral Health (continued) in the omitted the high priority symbol. On page 54023, Table B.8. Internal fourth column titled ‘‘CMS E-Measure On page 54123, Table B.25. Urology Medicine (continued), in the first ID’’, fourth row, we inadvertently listed (continued) in the first column titled column titled ‘‘Indicator’’, First and an incorrect E-measure ID. ‘‘Indicator’’, second rows, we inadvertently omitted On page 54091, Table B.19. Mental/ a. First, second, and third rows, we the high priority symbol. Behavioral Health (continued), we inadvertently omitted the high priority On pages 54024, Table B.8. Internal inadvertently included duplicate entries symbol. Medicine (continued), for Quality #286. On page 54124, Table B.26. Oncology a. Second column titled ‘‘NQF#’’, On page 54094, Table B.20a. in the first column titled ‘‘Indicator’’, third row, due to a typographical error, Diagnostic Radiology (continued) in the third row, we inadvertently omitted the amozie on DSK3GDR082PROD with RULES we included an incorrect NQF#. first column titled ‘‘Indicator’’, first row, high priority symbol. b. Ninth column titled ‘‘Measure we inadvertently omitted the high On page 54130, Table B.27. Steward’’, third row, we inadvertently priority symbol. Hospitalists (continued) in the first omitted the Centers for Medicare & On page 54098, Table B.20b. column titled ‘‘Indicator’’, first row, we Medicaid Services (CMS) as a co- Interventional Radiology (continued) in inadvertently omitted the high priority steward. the first column titled ‘‘Indicator’’, fifth symbol. VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00011 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23586 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations On page 54134, Table B.28. and Future Years, thirty-ninth row, is good cause to waive such Rheumatology (continued) in the first titled ‘‘Currently Eligible for Advancing requirements. Undertaking further column titled ‘‘Indicator’’, second row, Care Information Bonus’’, we incorrectly notice and comment procedures to we inadvertently omitted the high stated that this activity was not eligible incorporate the corrections in this priority symbol. for the Advancing Care Information document into the final rule or delaying On page 54136, Table B.29. Infectious Bonus. IA_PM_13 is eligible for the the effective date would be contrary to Disease (continued) in the first column Advancing Care Information Bonus. the public interest because it is in the titled ‘‘Indicator’’, second row, we public’s interest for providers to receive III. Waiver of Proposed Rulemaking, inadvertently omitted the high priority appropriate payments in as timely a 60-Day Comment Period, and Delay in symbol. manner as possible, and to ensure that Effective Date On page 54137, Table B.29. Infectious the CY 2018 Quality Payment Program Disease (continued) in the first column Under 5 U.S.C. 553(b) of the final rule accurately reflects our titled ‘‘Indicator’’, second row, we Administrative Procedure Act (APA), methodologies and policies. inadvertently omitted the CORE the agency is required to publish a Furthermore, such procedures would be measure symbol. notice of the proposed rule in the unnecessary, as we are not making On page 54138, Table B.29. Infectious Federal Register before the provisions substantive changes to our Disease (continued) in the first column of a rule take effect. Similarly, section methodologies or policies, but rather, titled ‘‘Indicator’’, fifth row, we 1871(b)(1) of the Act requires the we are simply implementing correctly inadvertently omitted the high priority Secretary to provide for notice of the the methodologies and policies that we and CORE measure symbols. proposed rule in the Federal Register previously proposed, requested On page 54139, Table B.29. Infectious and provide a period of not less than 60 comment on, and subsequently Disease (continued) in the first column days for public comment. In addition, finalized. This correcting document is titled ‘‘Indicator’’, first row, we section 553(d) of the APA, and section intended solely to ensure that the CY inadvertently omitted the high priority 1871(e)(1)(B)(i) of the Act mandate a 30- 2018 Quality Payment Program final symbol. day delay in effective date after issuance rule accurately reflects these On page 54141, Table B.30. or publication of a rule. Sections methodologies and policies. Therefore, Neurosurgical (continued) in the first 553(b)(B) and 553(d)(3) of the APA we believe we have good cause to waive column titled ‘‘Indicator’’, third row, we provide for exceptions from the notice the notice and comment and effective inadvertently omitted the high priority and comment and delay in effective date date requirements. symbol. APA requirements; in cases in which On page 54142, Table B.30. these exceptions apply, sections IV. Correction of Errors Neurosurgical (continued) in the first 1871(b)(2)(C) and 1871(e)(1)(B)(ii) of the In FR Doc. 2017–24067 (82 FR 53568), column titled ‘‘Indicator’’, Act provide exceptions from the notice make the following corrections: a. Fourth and fifth rows, we and 60-day comment period and delay inadvertently omitted the high priority in effective date requirements of the Act A. Correction of Errors in Preamble symbol. as well. Section 553(b)(B) of the APA 1. On page 53577, second column, On page 54145, Table B.31. Podiatry and section 1871(b)(2)(C) of the Act second full paragraph, line 10, the (continued) in the first column titled authorize an agency to dispense with phrase ‘‘of approximately $13.9 million ‘‘Indicator’’, first row, we inadvertently normal rulemaking requirements for relative’’ is corrected to read ‘‘of omitted the CORE measure symbol. good cause if the agency makes a approximately $14.2 million relative’’. On page 54146, Table B.32. Dentistry finding that the notice and comment 2. On page 53743, second column, (continued) in the first column titled process are impracticable, unnecessary, first full paragraph, under the heading ‘‘Indicator’’, first row, we inadvertently or contrary to the public interest. In ‘‘(iii) Additional Requirement for Full omitted the high priority symbol. addition, both section 553(d)(3) of the Participation To Measure Improvement On page 54163, Table E.1. CAHPS for APA and section 1871(e)(1)(B)(ii) of the for Quality Performance Category’’, line MIPS Clinician/Group Survey Act allow the agency to avoid the 30- 7, the reference ‘‘§ 414.1330’’ is a. First row titled ‘‘NQF#’’, due to a day delay in effective date where such corrected to read ‘‘§ 414.1335’’. typographical error, we included an delay is contrary to the public interest 3. On page 53744, third column, third incorrect NQF#. and an agency includes a statement of full paragraph, line 6, the reference b. Seventh row titled ‘‘Substantive support. ‘‘§ 414.1330’’ is corrected to read Change’’, we inadvertently omitted the We believe that this correcting ‘‘§ 414.1335’’. SSMs that remain for the measure. document does not constitute a rule that 4. On page 53900, second column, c. Eighth row titled ‘‘Steward’’, we would be subject to the notice and first partial paragraph, line 7, the phrase inadvertently omitted the Centers for comment or delayed effective date ‘‘burden cost of approximately $13.9’’ is Medicare & Medicaid Services (CMS) as requirements. The document corrects corrected to read ‘‘burden cost of a co-steward. technical errors in the CY 2018 Quality approximately $14.2’’. On page 54204, in Table G: Payment Program final rule, but does 5. On page 53911, third column, Improvement Activities with Changes not make substantive changes to the second full paragraph, line 3, the phrase for the Quality Payment Program Year 2 policies or payment methodologies that ‘‘approximately $695 million’’ is and Future Years, were adopted in the final rule. As a corrected to read ‘‘approximately $694 a. Eighteenth row, titled ‘‘Response’’, result, this correcting document is million’’. we inadvertently added qualifier intended to ensure that the information 6. On page 53925, first column, language that was incorrect. in the CY 2018 Quality Payment second full paragraph, line 6, the phrase amozie on DSK3GDR082PROD with RULES b. Nineteenth row, titled ‘‘Rationale’’ Program final rule accurately reflects the ‘‘total labor cost of $694,183,802’’ is we inadvertently added qualifier policies adopted in that document. corrected to read ‘‘total labor cost of language that was incorrect. In addition, even if this were a rule to ‘‘$693,949,289’’. On page 54216, in Table G: which the notice and comment 7. On page 53925, third column, first Improvement Activities with Changes procedures and delayed effective date full paragraph, line 3, the phrase ‘‘by for the Quality Payment Program Year 2 requirements applied, we find that there 171,264 hours and $13.9 million in’’ is VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00012 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23587 corrected to read ‘‘by 171,264 hours and ‘‘costs of $13.9 million in the Quality’’ column, Costs/benefits second row, the $14.2 million in’’. is corrected to read ‘‘costs of $14.2 dollar value ‘‘$13.9 million’’ is corrected 8. On page 53925, in Table 74— million in the Quality’’. to read ‘‘$14.2 million’’. Annual Recordkeeping And Submission 11. On page 53950, first column, first Requirements, sixth column, row 2, the full paragraph, line 4, the phrase ‘‘will B. Correction of Errors in Appendix total annual burden cost for QCDR and result in approximately $695’’ is 1. On page 53969, in Table A.3. Registries self-nomination ‘‘439,786’’ is corrected to read ‘‘will result in Average Change in Leg Pain following corrected to read ‘‘205,273’’. approximately $694’’. 9. On page 53925, in Table 74— 12. On page 53950, second column, Lumbar Discectomy/Laminotomy, the Annual Recordkeeping And Submission first partial paragraph, line 2, the phrase listed entry is corrected to read as Requirements, sixth column, row 19, the ‘‘period is and approximately $13.9’’ is follows: total annual burden cost ‘‘694,183,802’’ corrected to read ‘‘period is and BILLING CODE 4120–01–P is corrected to read ‘‘693,949,289’’. approximately $14.2’’. 10. On page 53927, first column, first 13. On page 53950, Table 81, partial paragraph, line 4, the phrase Additional Costs And Benefits second 2. On page 53970, in Table A.4. Bone Prostate Cancer and Receiving listed entry is corrected to read as Density Evaluation for Patients with Androgen Deprivation Therapy, the follows: 3. On page 53971, in Table A.5, (POV)—Combination Therapy (Pediatrics) the listed entry is corrected Prevention of Post-Operative Vomiting to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.001</GPH> ER22MY18.000</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00013 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23588 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 4. On page 53973, in Table A.7, Documentation of Angiographic Arteries, the listed entry is corrected to Uterine Artery Embolization Technique: Endpoints and Interrogation of Ovarian read as follows: 5. On pages 53976, 53977 and 53978, listed entries are corrected to read as in Table B.1 Allergy/Immunology, the follows: amozie on DSK3GDR082PROD with RULES ER22MY18.003</GPH> ER22MY18.002</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00014 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23589 6. On pages 53985, 53986, and 53987, listed entries are corrected to read as in Table B.3 Cardiology (continued), the follows: amozie on DSK3GDR082PROD with RULES ER22MY18.004</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00015 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23590 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 7. On page 53992, in Table B.4 Gastroenterology (continued), the listed entry is corrected to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.006</GPH> 8. On page 53997, in Table B.5 Dermatology (continued), the listed entries are corrected to read as follows: ER22MY18.005</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00016 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23591 9. On page 54006, 54007, 54009, Family Medicine (continued) the listed 54010, 54012, and 54013, in Table B.7 entries are corrected to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.007</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00017 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23592 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations B.7. Family Medicine (continued) § 0062 119 134v6 Registry, Process Effective Diabetes: Medical Attention for National EHR Clinical Nephropathy: The percentage of Committee for Care patients 18-75 years of age with Quality diabetes who had a nephropathy Assurance screening test or evidence of nephropathy during the measurement 0419 130 68v7 Claims, Process Patient Documentation of Current Centers for Registry, Safety Medications in the Medical Medicare & EHR Record: Medicaid Percentage of visits for patients Services aged 18 years and older for which the eligible professional attests to documenting a list of current medications using all immediate resources available on the date of the encounter. This list must include ALL known prescriptions, over-the-counters, herbals, and vitamin/mineral!dietary (nutritional) supplements AND must contain the medications' name, dosage, frequency and route of administration. * 0022 238 156v6 Registry, Process Patient Use of High-Risk Medications in National EHR Safety the Elderly: Committee for Percentage of patients 65 years of Quality age and older who were ordered Assurance high-risk medications. Two rates are reported. a. Percentage of patients who were ordered at least one high-risk medication. b. Percentage of patients who were ordered at least two of the same -risk medications. 0643 243 N/A Registry Process Communi Cardiac Rehabilitation Patient American cation and Referral from an Outpatient College of Care Setting: Cardiology Coordinati Percentage of patients evaluated in Foundation on an outpatient setting who within the previous 12 months have experienced an acute myocardial infarction (MI), coronary artery bypass graft (CABG) surgery, a percutaneous coronary intervention (PCI), cardiac valve surgery, or cardiac transplantation, or who have chronic stable angina (CSA) and have not already participated in an early outpatient cardiac amozie on DSK3GDR082PROD with RULES ER22MY18.008</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00018 Fmt 4700 Sfmt 4725 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23593 10. On pages 54023, 54024, and (continued), the listed entries are 54027, in Table B.8 Internal Medicine corrected to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.009</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00019 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23594 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations B.S. Internal Medicine (continued) * 0022 238 156v6 EHR, Process Patient Use of High-Risk Medications National Registry Safety in the Elderly: Committee Percentage of patients 65 years for Quality of age and older who were Assurance ordered high-risk medications. Two rates are reported. a. Percentage of patients who were ordered at least one high- risk medication. b. Percentage of patients who were ordered at least two of the same medications. 0643 243 N/A Registry Process Communi cat Cardiac Rehabilitation Patient American ion and Care Referral from an Outpatient College of Coordination Setting: Cardiology Percentage of patients evaluated Foundation in an outpatient setting who within the previous 12 months have experienced an acute myocardial infarction (MI), coronary artery bypass graft (CABG) surgery, a percutaneous coronary intervention (PCI), cardiac valve surgery, or cardiac transplantation, or who have chronic stable angina (CSA) and have not already participated in an early outpatient cardiac rehabilitation/secondary prevention (CR) program for the qualifying event/diagnosis who were referred to a CR program. * 0005 321 N/A CMS- Patient Person and CAHPS for MIPS Agency for § approved Engagement/ Caregiver- Clinician/Group Survey: Healthcare Survey Experience Centered Summary Survey Measures may Research & Vendor Experience include: Quality and • Getting Timely Care, (AHRQ), Outcomes Appointments, and Information; Centers for • How well Providers Medicare & Communicate; Medicaid • Patient's Rating of Provider; Services • Access to Specialists; • Health Promotion and Education; • Shared Decision-Making; • Health Status and Functional Status; • Courteous and Helpful Office Staff; • Care Coordination; • Stewardship of Patient Resources. amozie on DSK3GDR082PROD with RULES ER22MY18.010</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00020 Fmt 4700 Sfmt 4725 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23595 11. On pages 54036, 54037, and Gynecology (continued), the listed 54038, in Table B.9 Obstetrics/ entries are corrected to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.012</GPH> 12. On pages 54047 and 54049, in (continued), the listed entries are Table B.11 Orthopedic Surgery corrected to read as follows: ER22MY18.011</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00021 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23596 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 13. On page 54079, in Table B.18 Neurology (continued), the listed entries are corrected to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.013</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00022 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23597 14. On page 54082, in Table B.18 15. On page 54086, 54089, and 54091, (continued), the listed entries are Neurology (continued), the third row in Table B.19 Mental/Behavioral Health corrected to read as follows: (including the Quality #286) is removed. amozie on DSK3GDR082PROD with RULES ER22MY18.014</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00023 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23598 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 16. On page 54091, in Table B.19 17. On page 54094, in Table B.20a Mental/Behavioral Health (continued), Diagnostic Radiology (continued), the the third row (including the Quality listed entry is corrected to read as #286) is removed. follows: amozie on DSK3GDR082PROD with RULES ER22MY18.015</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00024 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23599 18. On page 54098 and 54099, in the listed entries are corrected to read as Table B.20b Interventional Radiology, follows: 19. On pages 54102 and 54103, in listed entries are corrected to read as Table B.21 Nephrology (continued), the follows: amozie on DSK3GDR082PROD with RULES ER22MY18.017</GPH> ER22MY18.016</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00025 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23600 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 20. On pages 54109, 54112, and (continued), the listed entries are 54113, in Table B.23 Vascular Surgery corrected to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.018</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00026 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23601 21. On pages 54116 and 54118, in (continued), the listed entries are Table B.24 Thoracic Surgery corrected to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.019</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00027 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23602 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 22. On page 54121, 54122, and 54123, listed entries are corrected to read as in Table B.25 Urology (continued), the follows: amozie on DSK3GDR082PROD with RULES ER22MY18.020</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00028 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23603 B.25. Urology (continued) 0419 130 68v7 Claims, Process Patient Documentation of Current Centers for Registry, Safety Medications in the Medical Record: Medicare& EHR Percentage of visits for patients aged Medicaid 18 years and older for which the Services eligible professional attests to documenting a list of current medications using all immediate resources available on the date of the encounter. This list must include ALL known prescriptions, over-the- counters, herbals, and vitamin/mineraVdietary (nutritional) supplements AND must contain the medications' name, dosage, frequency and route of administration. N/A 429 N/A Claims, Process Patient Pelvic Organ Prolapse: American Registry Safety Preoperative Screening for Uterine Urogynecologi Malignancy: c Society Percentage of patients who are screened for uterine malignancy prior to vaginal closure or obliterative for N/A 432 N/A Registry Outcome Patient Proportion of Patients Sustaining a American Safety Bladder Injury at the Time of any Urogynecologi Pelvic Organ Prolapse Repair: c Society Percentage of patients undergoing any surgery to repair pelvic organ prolapse who sustains an injury to the bladder recognized either during or within 1 month after N/A 433 N/A Registry Outcome Patient Proportion of Patients Sustaining a American Safety Bowel Injury at the time of any Urogynecologi Pelvic Organ Prolapse Repair: c Society Percentage of patients undergoing surgical repair of pelvic organ prolapse that is complicated by a bowel injury at the time of index surgery that is recognized intraoperatively or within 1 month after N/A 434 N/A Registry Outcome Patient Proportion of Patients Sustaining a American Safety Ureter Injury at the Time of any Urogynecologi Pelvic Organ Prolapse Repair: c Society Percentage of patients undergoing pelvic organ prolapse repairs who sustain an injury to the ureter recognized either during or within 1 month after 23. On page 54124, in Table B.26 Oncology, the listed entry is corrected to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.021</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00029 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23604 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 24. On page 54130, in Table B.27 Hospitalists (continued), the listed entry is corrected to read as follows: 25. On page 54134, Table B.28 Rheumatology (continued), the listed entry is corrected to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.023</GPH> ER22MY18.022</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00030 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23605 26. On pages 54136, 54137, 54138, Disease (continued), the listed entries and 54139, in Table B.29. Infectious are corrected to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.024</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00031 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23606 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations B.29. Infectious Disease (continued) 0419 130 68v7 Claims, Process Patient Documentation of Current Centers for Registry, Safety Medications in the Medical Record: Medicare & EHR Percentage of visits for patients aged 18 Medicaid years and older for which the eligible Services professional attests to documenting a list of current medications using all immediate resources available on the date of the encounter. This list must include ALL known prescriptions, over- the-counters, herbals, and vitamin/mineraVdietary (nutritional) supplements AND must contain the medications' name, dosage, frequency and route of administration. § N/A 275 N/A Registry Process Effective Inflammatory Bowel Disease (IBD): American Clinical Assessment of Hepatitis B Virus Gastro- Care (HBV) Status Before Initiating Anti- TNF (Tumor Necrosis Factor) Association Therapy: Percentage of patients aged 18 years and older with a diagnosis of inflammatory bowel disease (IBD) who had Hepatitis B Virus (HBV) status assessed and results interpreted within one year prior to receiving a first course of anti-TNF (tumor necrosis factor) HIV Medical Visit Frequency: Percentage of patients, regardless of age Health Efficiency with a diagnosis ofHIV who had at Resources 2079 340 N/A Registry Process and Cost least one medical visit in each 6 month and Services § Reduction period of the 24 month measurement Administrati period, with a minimum of 60 days on between medical visits Hepatitis C: Discussion and Shared Decision Making Surrounding Treatment Options: Percentage of patients aged 18 years and older with a diagnosis of hepatitis C with whom a physician or other qualified healthcare professional Person reviewed the range of treatment options and appropriate to their genotype and American Caregiver- demonstrated a shared decision making Gastroentero N/A 390 N/A Registry Process Centered approach with the patient. To meet the logical Experienc measure, there must be documentation Association e and in the patient record of a discussion Outcomes between the physician or other qualified healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment amozie on DSK3GDR082PROD with RULES 27. On pages 54141 and 54142, in Table B.30 Neurosurgical, the listed entries are corrected to read as follows: ER22MY18.025</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00032 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23607 28. On page 54145, in Table B.31 Podiatry (continued), the listed entry is corrected to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.026</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00033 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23608 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 29. On page 54146, in Table B.32 Dentistry, the listed entry is corrected to read as follows: 30. On page 54163, in Table E.1, Survey, the listed entries are corrected CAHPS for MIPS Clinician/Group to read as follows: amozie on DSK3GDR082PROD with RULES ER22MY18.028</GPH> ER22MY18.027</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00034 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations 23609 31. On page 54204, in Table G and Future Years, the following entries Improvement Activities with Changes are corrected to read as follows: for the Quality Payment Program Year 2 32. On page 54216, in Table G and Future Years, the following entries Improvement Activities with Changes are corrected to read as follows: for the Quality Payment Program Year 2 ER22MY18.030</GPH> ER22MY18.031</GPH> amozie on DSK3GDR082PROD with RULES BILLING CODE 4120–01–C facilities, Health professions, Diseases, Accordingly, 42 CFR chapter IV is List of Subjects in 42 CFR Part 414 Medicare, Reporting and recordkeeping corrected by making the following requirements. correcting amendments: Administrative practice and procedure, Biologics, Drugs, Health ER22MY18.029</GPH> VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00035 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1

23610 Federal Register / Vol. 83, No. 99 / Tuesday, May 22, 2018 / Rules and Regulations PART 414—PAYMENT FOR PART B DEPARTMENT OF HOMELAND insurance unless an appropriate public MEDICAL AND OTHER HEALTH SECURITY body adopts adequate floodplain SERVICES management measures with effective Federal Emergency Management enforcement measures. The ■ 1. The authority citation for part 414 Agency communities listed in this document no continues to read as follows: longer meet that statutory requirement Authority: Secs. 1102, 1871, and 1881(b)(l) 44 CFR Part 64 for compliance with program of the Social Security Act (42 U.S.C. 1302, [Docket ID FEMA–2018–0002; Internal regulations, 44 CFR part 59. 1395hh, and 1395rr(b)(l)). Accordingly, the communities will be Agency Docket No. FEMA–8531] ■ 2. Section 414.1370 is amended by suspended on the effective date in the revising paragraphs (g)(1)(ii)(B) and Suspension of Community Eligibility third column. As of that date, flood (h)(5)(i)(B) to read as follows: insurance will no longer be available in AGENCY: Federal Emergency the community. We recognize that some § 414.1370 APM scoring standard under Management Agency, DHS. of these communities may adopt and MIPS. ACTION: Final rule. submit the required documentation of * * * * * legally enforceable floodplain (g) * * * SUMMARY: This rule identifies management measures after this rule is (1) * * * communities where the sale of flood published but prior to the actual (ii) * * * insurance has been authorized under (B) Quality Improvement Score. suspension date. These communities the National Flood Insurance Program will not be suspended and will continue Beginning in 2018, for an APM Entity (NFIP) that are scheduled for for which CMS calculated a total quality to be eligible for the sale of NFIP flood suspension on the effective dates listed insurance. A notice withdrawing the performance category score for the within this rule because of previous MIPS performance period, suspension of such communities will be noncompliance with the floodplain published in the Federal Register. CMS calculates a quality improvement management requirements of the In addition, FEMA publishes a Flood score for the APM Entity group, as program. If the Federal Emergency Insurance Rate Map (FIRM) that specified in § 414.1380(b)(1)(xvi). Management Agency (FEMA) receives identifies the Special Flood Hazard * * * * * documentation that the community has Areas (SFHAs) in these communities. (h) * * * adopted the required floodplain The date of the FIRM, if one has been (5) * * * management measures prior to the published, is indicated in the fourth (i) * * * effective suspension date given in this (B) Beginning in 2018, the advancing column of the table. No direct Federal rule, the suspension will not occur and financial assistance (except assistance care information performance category a notice of this will be provided by is reweighted to 75 percent and the pursuant to the Robert T. Stafford publication in the Federal Register on a Disaster Relief and Emergency improvement activities performance subsequent date. Also, information Assistance Act not in connection with a category is reweighted to 25 percent. identifying the current participation flood) may be provided for construction * * * * * status of a community can be obtained or acquisition of buildings in identified § 414.1380 [Amended] from FEMA’s Community Status Book SFHAs for communities not (CSB). The CSB is available at https:// participating in the NFIP and identified ■ 3. Section 414.1380 is amended in www.fema.gov/national-flood- for more than a year on FEMA’s initial paragraph (b)(1)(xvi)(F) by removing the insurance-program-community-status- FIRM for the community as having reference ‘‘§§ 414.1330’’ and adding in book. flood-prone areas (section 202(a) of the its place the reference ‘‘§§ 414.1335’’. Flood Disaster Protection Act of 1973, ■ 4. Section 414.1420 is amended by DATES: The effective date of each community’s scheduled suspension is 42 U.S.C. 4106(a), as amended). This revising paragraph (d)(3)(i) to read as prohibition against certain types of follows: the third date (‘‘Susp.’’) listed in the third column of the following tables. Federal assistance becomes effective for § 414.1420 Other payer advanced APM the communities listed on the date FOR FURTHER INFORMATION CONTACT: If criteria. shown in the last column. The you want to determine whether a Administrator finds that notice and * * * * * particular community was suspended (d) * * * public comment procedures under 5 on the suspension date or for further U.S.C. 553(b), are impracticable and (3) * * * information, contact Adrienne L. (i) For the 2019 and 2020 QP unnecessary because communities listed Sheldon, PE, CFM, Federal Insurance in this final rule have been adequately Performance Periods, 8 percent of the and Mitigation Administration, Federal notified. total combined revenues from the payer Emergency Management Agency, 400 C Each community receives 6-month, to providers and other entities under the Street SW, Washington, DC 20472, (202) 90-day, and 30-day notification letters payment arrangement if financial risk is 212–3966. addressed to the Chief Executive Officer expressly defined in terms of revenue; or, 3 percent of the expected SUPPLEMENTARY INFORMATION: The NFIP stating that the community will be expenditures for which an APM Entity enables property owners to purchase suspended unless the required is responsible under the payment Federal flood insurance that is not floodplain management measures are arrangement; or otherwise generally available from met prior to the effective suspension private insurers. In return, communities date. Since these notifications were * * * * * agree to adopt and administer local made, this final rule may take effect amozie on DSK3GDR082PROD with RULES Dated: May 16. 2018. floodplain management measures aimed within less than 30 days. Ann C. Agnew, at protecting lives and new construction National Environmental Policy Act. Executive Secretary to the Department, from future flooding. Section 1315 of FEMA has determined that the Department of Health and Human Services. the National Flood Insurance Act of community suspension(s) included in [FR Doc. 2018–10923 Filed 5–21–18; 8:45 am] 1968, as amended, 42 U.S.C. 4022, this rule is a non-discretionary action BILLING CODE 4120–01–P prohibits the sale of NFIP flood and therefore the National VerDate Sep<11>2014 15:59 May 21, 2018 Jkt 244001 PO 00000 Frm 00036 Fmt 4700 Sfmt 4700 E:\FR\FM\22MYR1.SGM 22MYR1


Document Created: 2018-11-02 11:10:06
Document Modified: 2018-11-02 11:10:06
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionRules and Regulations
ActionFinal rule with comment period and interim final rule with comment period; correction and correcting amendment.
DatesThis correction is effective May 22, 2018.
ContactMolly MacHarris, (410) 786-4461, for inquiries related to MIPS.
FR Citation83 FR 23584 
RIN Number0938-AT13
CFR AssociatedAdministrative Practice and Procedure; Biologics; Drugs; Health Facilities; Health Professions; Diseases; Medicare and Reporting and Recordkeeping Requirements
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR